Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04471935 · ClinicalTrials.gov registry record · NA
Speech Hero Home Therapy for Aphasia
A NA study of Broca Aphasia, sponsored by Flint Rehabilitation Devices.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT04471935: Completed NA study of Broca Aphasia, sponsored by Flint Rehabilitation Devices.
NCT04471935 is a NA study of Broca Aphasia that has completed, run by Flint Rehabilitation Devices. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04471935, a NA study of Broca Aphasia, has completed, sponsored by Flint Rehabilitation Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators will run an at-home usability study of a newly developed speech therapy app called Speech Hero with 10 individuals with Broca's aphasia in the chronic stage of stroke. The Speech Hero app allows users to perform rhythm-based speech exercises at home. For this study participants will be instructed to use Speech Hero for at least 10 hours over a 4-week period.
Primary Outcome
Number of participants able to use the device on their own at home for at least 10 hours over four weeks without technical or other issues. Speech Hero will be deemed feasible for this population if at least 5 participants are able to use the device on their own at home for at least 10 hours over four weeks without technical or other issues.
Conditions Studied
Interventions
- DEVICE At home Speech Hero therapy app
Study Locations (1)
Texas
- Callier Center at University of Texas Dallas - Richardson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-07-20 |
| Est. Completion | 2021-10-20 |
| Phase | NA |
What the finished NCT04471935 record still lists
NCT04471935 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Broca Aphasia appearing as the primary indexed condition, and to 1 intervention - of which At home Speech Hero therapy app is the first listed.
NCT04471935 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04471935 about?
NCT04471935 is a clinical study titled "Speech Hero Home Therapy for Aphasia". The investigators will run an at-home usability study of a newly developed speech therapy app called Speech Hero with 10 individuals with Broca's aphasia in the chronic stage of stroke. The Speech Hero app allows users to perform rhythm-based speech exercises at home. For this study participants wil...
What is the current status of trial NCT04471935?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2021-07-20. Estimated completion is 2021-10-20.
What conditions does trial NCT04471935 study?
This clinical trial studies the following conditions: Broca Aphasia.
What interventions are being tested in trial NCT04471935?
The interventions under investigation include: At home Speech Hero therapy app (DEVICE).
Who is sponsoring clinical trial NCT04471935?
This trial is sponsored by Flint Rehabilitation Devices, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04471935 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04471935's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI